Clinical Trials Sponsored by GeneCure Biotechnologies

Total 190 results

Laboratoire français de Fractionnement et de Biotechnologies

Completed

Efficacy and Safety Study of I10E in Treatment of Patients With CIDP (PRISM)

Chronic Inflammatory Demyelinating Polyradiculoneuropathy

Spain, United Kingdom, Italy, France, Tunisia, Turkey
Laboratoire français de Fractionnement et de Biotechnologies

Completed

Fibrinogen in Haemorrhage of Delivery (FIDEL)

Post-Partum Hemorrhage

France, Martinique
Laboratoire français de Fractionnement et de Biotechnologies

Completed

Pharmacokinetics and Safety of Roledumab in RhD-negative Pregnant Women Carrying an RhD-positive Foetus

Rh Disease

France
Laboratoire français de Fractionnement et de Biotechnologies

Completed

Willebrand International Non-interventional Global Surveillance

Von Willebrand Disease

Norway, Germany, Italy, Belgium, Czechia, Finland, Greece
Laboratoire français de Fractionnement et de Biotechnologies

Completed

Human Fibrinogen Concentrate (FGTW) in Pediatric Patients With Congenital Fibrinogen Deficiency

Hypofibrinogenemia, Congenital | Afibrinogenemia, Congenital

France, Lebanon, Morocco, Turkey
Laboratoire français de Fractionnement et de Biotechnologies

Recruiting

Retrospective Experience Assessing the Real-World Utilization and Effectiveness of SEVENFACT®

Hemophilia

United States
Memorial Sloan Kettering Cancer Center
Illuminare Biotechnologies

Recruiting

Fluorescent Imaging of Nerves With Illuminare-1 During Surgery

Prostate Adenocarcinoma

United States
Immatics Biotechnologies GmbH
National Cancer Institute (NCI)

Terminated

Peptide-based Glioma Vaccine IMA950 in Patients With Glioblastoma

Glioblastoma

United States
Laboratoire français de Fractionnement et de Biotechnologies

Completed

LFB-R603 Dose Finding in Patients With Advanced Stage B-Chronic Lymphocytic Leukemia

Chronic Lymphocytic Leukemia

France
Laboratoire français de Fractionnement et de Biotechnologies

Completed

Early Albumin Resuscitation During Septic Shock

Septic Shock

France
Eyecure Therapeutics Inc.
Beijing Tongren Hospital

Unknown

Treatment of RP and LCA by Primary RPE Transplantation

Leber Congenital Amaurosis, Retinitis Pigmentosa

China
Laboratoire français de Fractionnement et de Biotechnologies

Recruiting

A Phase 3 Study of the Safety and Efficacy of Coagulation Factor VIIa (Recombinant) for the Prevention of Excessive Bleeding in Patients With Congenital Hemophilia A or B With Inhibitors to Factor VIII or IX Undergoing Elective Major Surgical Procedures SCOPE HIM (SCOPE HIM)

Hemophilia

United States, Thailand, Malaysia, Mexico, Turkey, South Africa
Laboratoire français de Fractionnement et de Biotechnologies

Completed

Safety Study of Alfalastin (Human Alpha-1 Antitrypsin) Administered at Home

Alpha 1-Antitrypsin Deficiency
Laboratoire français de Fractionnement et de Biotechnologies

Terminated

Efficacy and Safety Study of I10E in the Maintenance Treatment of Patients With CIDP: Extension of PRISM Study I10E-1302 (PRISM2)

Chronic Inflammatory Demyelinating Polyradiculoneuropathy

Spain, Italy, France, Tunisia, United Kingdom, Turkey
Throne Biotechnologies Inc.
Chinese PLA General Hospital

Unknown

Stem Cell Educator Therapy in Diabetes

Diabetes Mellitus, Type 2 | Diabetes Mellitus, Type 1

China
Laboratoire français de Fractionnement et de Biotechnologies

No longer available

HEMOLEVEN® Expanded Access Program Prevention of Surgical/Postpartum Hemorrhage Severe Inherited Factor XI Deficiency (EAP)

Surgery | Postpartum Hemorrhage | Wound; Rupture, Surgery, Cesarean Section

United States
University of Calgary
IMBiotechnologies Ltd.

Not yet recruiting

Evaluate the Safety and Effectiveness of Using Echogenic Embolic Agent for Embolization of Prostate Artery for Treatment of Men With BPH (PAE CEUS) (PAE CEUS)

Benign Prostatic Hyperplasia
Laboratoire français de Fractionnement et de Biotechnologies
Parexel

Completed

Dose-finding Study of LFB-R593, A Monoclonal Anti-RhD Antibody, in Healthy RhD Negative Volunteers

Healthy

Germany
University Medical Centre Ljubljana
Innovacell Biotechnologie AG

Completed

Safety and Efficacy Study of Intrasphincteric Autologous Myoblast Injection to Treat Stress Urinary Incontinence

Stress Urinary Incontinence

Slovenia
SmartWithFood
KU Leuven; Vlaams Instituut voor Biotechnologie

Unknown

Health Improvement Through Food and Lifestyle Intervention Based On Personalized Retail Advice (FLORA)

Metabolic Syndrome | Gut Bacteria | Personalized Nutrition
Minerva Biotechnologies Corporation
City of Hope Medical Center

Recruiting

Autologous huMNC2-CAR44 or huMNC2-CAR22 T Cells for Breast Cancer Targeting Cleaved Form of MUC1 (MUC1*)

Metastatic Breast Cancer

United States
University of Western Ontario, Canada
Mirexus Biotechnologies Inc

Unknown

Dose Response Oxidation of a Sweet-corn Derived Sugar (PhytoSpherix) During Exercise in Endurance Trained Athletes

Hypoglycemia

Canada
University Hospital, Geneva
Oncovir, Inc.; Immatics Biotechnologies GmbH

Completed

Phase I/II Trial of IMA950 Multi-peptide Vaccine Plus Poly-ICLC in Glioblastoma

CNS Tumor, Adult

Switzerland
Notitia Biotechnologies Company
University of South Florida; Rutgers University

Completed

NBT-NM108 as an Early Treatment for Suspected or Confirmed Symptomatic COVID-19 Patients (COVGUT20)

Suspected or Confirmed COVID-19

United States
rEVO Biologics
Laboratoire français de Fractionnement et de Biotechnologies

Completed

Phase III Study of Coagulation FVIIa (Recombinant) in Congenital Hemophilia A or B Patients With Inhibitors

Hemophilia A With Inhibitors | Hemophilia B With Inhibitors

United States, Bulgaria, Poland, Russian Federation, Belarus, Georgia, Israel, Romania, Ukraine, United Kingdom
Lions Eye Institute, Perth, Western Australia
Adverum Biotechnologies, Inc.

Completed

Safety and Efficacy Study of rAAV.sFlt-1 in Patients With Exudative Age-Related Macular Degeneration (AMD)

Eye Diseases | Macular Degeneration | Retinal Degeneration | Retinal Neovascularization | Age-related Maculopathies | Age-related Maculopathy | Maculopathies,Age-related | Maculopathy,Age-related

Australia
Guangzhou Medical University
Ningbo SensCure Biotechnology Co., Ltd.

Recruiting

Single-center Clinical Study on the Safety and Effect of Bronchoscopic Cryotherapy in Patients With Chronic Cough (ColdCough)

Chronic Cough

China
Geneticure, LLC
University of Minnesota; Fairview Health Services

Not yet recruiting

Investigating the Use of Genetics to Guide Pharmacologic Therapy for Hypertension (PGEN for HTN)

Hypertension

United States
Universitaire Ziekenhuizen KU Leuven
Vlaams Instituut Biotechnologie (VIB)

Recruiting

Drug Repurposing - Statins as Microbiota Modulating Agents in Ulcerative Colitis (ReMiDy)

Ulcerative Colitis

Belgium
Throne Biotechnologies Inc.
Second Xiangya Hospital of Central South University

Unknown

Reversal of Type 1 Diabetes in Children by Stem Cell Educator Therapy

Type 1 Diabetes

China
Laboratoire français de Fractionnement et de Biotechnologies
LFB USA, Inc.

Completed

A Phase III Study on the Safety, Pharmacokinetics and Efficacy of Coagulation Factor VIIa (PERSEPT2)

Hemophilia A With Inhibitors | Hemophilia B With Inhibitors

Bulgaria, Ukraine, Czechia, United States, Georgia, South Africa
University Hospital, Lille
Laboratoire français de Fractionnement et de Biotechnologies

Completed

Effect of Anti-CD303 Antibodies in Autoimmune Diseases (ANTI-CD303)

Immune Disease

France
University Hospital, Angers
Laboratoire français de Fractionnement et de Biotechnologies

Unknown

TOADS Study: TO Assess Death From Septic Shock. (TOADS)

Septic Shock
University Hospital, Limoges
Laboratoire français de Fractionnement et de Biotechnologies

Terminated

Perioperative Coagulation Management in Cardiac Surgery. (ROTEM)

Bleeding | Cardiac Surgery

France
RepliCel Life Sciences, Inc.
Syreon Corporation; Innovacell Biotechnologie AG

Terminated

Safety and Efficacy of RCT-01 in Men and Women With Unilateral, Chronic Achilles Tendinosis (ReaCT)

Tendinopathy | Tendinosis

Canada
H. Lee Moffitt Cancer Center and Research Institute
Adaptive Biotechnologies

Recruiting

Multiple Myeloma Outcomes Based on Maintenance Therapy Post Autologous Stem Cell Transplant

Multiple Myeloma

United States
Laboratoire français de Fractionnement et de Biotechnologies
LFB USA, Inc.

Completed

LR769 in Congenital Hemophilia Patients With Inhibitors Undergoing Elective Surgery or Invasive Procedures (PerSept3)

Hemophilia

United States, Ukraine, Mexico, Russian Federation, South Africa, Spain
Throne Biotechnologies Inc.
The First Hospital of Hebei Medical University

Unknown

Stem Cell Educator Therapy in Alopecia Areata

Alopecia Areata

China
Hospices Civils de Lyon
Laboratoire français de Fractionnement et de Biotechnologies

Completed

Management of Coagulopathy During Orthotopic Liver Transplantation. Comparison Between ROTEM-based Management and Standard Biological Assessment.

Liver Transplantation

France
University Hospital, Ghent
University Ghent; Vlaams Instituut voor Biotechnologie

Completed

Local and General Immune Response After Coronavirus Disease (COVID-19) Vaccination in Volunteers (COVACC2)

Covid19

Belgium
Nuwacell Biotechnologies Co., Ltd.
Shanghai 6th People's Hospital; Beijing Luhe Hospital

Not yet recruiting

A Trial to Evaluate the Safety, Tolerability, and Efficacy of NCR100 Injection in the Treatment of Subjects With KOA (NCR100)

Knee Osteoarthritis
Laboratoire français de Fractionnement et de Biotechnologies
TFS Trial Form Support

Completed

LIME Study (LFB IVIg MMN Efficacy Study) (LIME)

Motor Neuron Disease

Spain, United Kingdom, Italy, France
Ruijin Hospital
Frontier Biotechnologies Inc.; Shanghai Center for Disease Control and Prevention

Not yet recruiting

Exploratory Study of Aerosol Inhalation of FB2001 for Post-exposure Prophylaxis of COVID-19 Close Contacts

Close Contact Transmission
University of Electronic Science and Technology...
Chengdu Nuoen Biotechnologies, Inc.

Unknown

Dynamic Monitoring of Circulating microRNA Changes in Patients With or Without Multiple Organ Failure

Multiple Organ Failure

China
Affiliated Hospital to Academy of Military Medical...
Hangzhou ImmuQuad Biotechnologies, LLC

Completed

Characteristics and Dynamics of TCR Repertoire in Patients With Hematological Malignancies After Allo-HSCT

Recurrence | Hematologic Neoplasms | Hematopoietic Stem Cell Transplantation | Graft Vs Host Disease

China
Société Française d'Anesthésie et de Réanimation
Laboratoire français de Fractionnement et de Biotechnologies

Not yet recruiting

Perioperative Hemostasis Management in Liver Transplantation (HEMOTRANSPLANT)

Liver Transplant; Complications

France
Second Affiliated Hospital, School of Medicine,...
Zhejiang Ruijiamei Biotechnologies, Co., Ltd.

Recruiting

Clinical Study of the Efficacy of CD19-CAR-DNT Cells in the Treatment of Relapsed/Refractory B-cell NHL

B-cell Non-Hodgkin's Lymphoma

China
Proneuron Biotechnologies
The Marcus Foundation; B.I.R.D. (Israel-U.S. Binational Industrial Research...

Suspended

Autologous Incubated Macrophages for Patients With Complete Spinal Cord Injuries

Spinal Cord Injury

Israel, United States
Centre Hospitalier Universitaire de Saint Etienne
Laboratoire français de Fractionnement et de Biotechnologies

Completed

Randomized Open-label Trial to Compare Efficacy and Tolerance of Corticosteroids and IVIg (PRNC)

Demyelinating Polyneuropathy

France
University Medical Center Groningen
University of Twente; Vivisol; Löwenstein BV; Sencure BV

Not yet recruiting

Improving Chronic Nocturnal Noninvasive Ventilation: a Multimodality Approach (NOCTIVENT)

Chronic Respiratory Failure | Non-invasive Ventilation

Clinical Trials Sponsored by GeneCure Biotechnologies

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Bahamas

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations